Similarly, high levels of RhoA signaling, coupled with elevated activation of MRTFA and YAP1, promotes BRAFi resistance in dedifferentiated melanoma cell lines characterized by a decreased expression of melanocyte lineage genes. This evidence concerns the gene MRTFA and melanoma.